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1. Introduction     
Differentiation toward cardiomyocytes from embryonic stem cells (ESCs) and induced 
pluripotent stem cells (iPSCs) has been studied widely. Many of ESC/iPSC differentiation 
methods have been developed using embryoid body (EB) methods, in which ESCs/iPSCs 
spontaneously differentiate in floating aggregates. Various marker genes (early mesoderm 
or mesoendoderm cells: Brachyury, mesoderm cells: Mesp1, Flk1, and Pdgfra, cardiac 
progenitors: Nkx2.5, Islet1 and cardiomyocytes: myosin chains) have been identified as stage 
specific markers to recapitulate developmental process in embryo. The clues from 
developmental biology provided ideas to use growth factors (Activin A/Nodal, Bmp4, 
Cerberus, Wnt3a, and Wnt11) to guide cardiac differentiation. Recently these stem cell 
technologies have been combined with chemical biology, in which small molecules are 
identified and used to regulate cell fate or modulate cell reprogramming. Several chemicals 
were reported that they could enhance cardiomyocyte differentiation from embryonic stem 
cells. However, it is hard to determine how these chemicals work, which cell types they 
affect, and what are their molecular targets because of heterogeneity in EBs. We have 
established a novel systemic cardiovascular differentiation method that is based on two 
dimensional culture and sequential purification using cell surface markers. A mesoderm 
lineage population, Flk1 expressing cells derived from mouse ESC/iPSC can give rise to 
vascular endothelial cells, pericytes, hematopoietic cells, and cardiomyocytes. 
Cardiomyocytes appear after 4 days co-culture of Flk1+ cells on OP9 feeder cells. A cardiac 
progenitor population, FCV (Flk1+/CXCR4+/Vascular endothelial cardherin-) cells among 
the progeny of Flk1+ mesoderm cells are observed 2 days after Flk1 purification. In our 
system, Flk1+ and FCV cells are able to give rise to all cardiovascular cells - cardiomyocytes, 
endothelial cells, and pericyte even from single cell. We have identified a novel cardiogenic 
effect of cyclosporin-A (CsA) well-known immunosuppressant. CsA affects on mesoderm 
cells to drastically increase the differentiation of cardiac progenitors and cardiomyocytes up 
to 10 fold. In this chapter, we review recent advances of combination of stem cell 
technologies and chemical biology, especially chemical biology on cardiomyocyte 
differentiation, and our resent findings. We also describe some information to compare high 
throughput screening and high content screening in cell based assay.  
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2. Heart development in vivo and cardiomyocyte differentiation in vitro 
To understand how cardiomyocytes differentiate from ESCs/iPSCs, comparison between 
embryo and ESC/iPSC differentiation would be helpful. In this section, we describe how a 
heart develops in an embryo, and how cardimyocytes differentiate from ESCs/iPSCs. 
(Figure 1 and 2) 
2.1 Heart development in vivo 
The heart is the first functional organ in mammals. After fertilization, a Zygote cleaves and 
forms blastcyst before implantation (-E3.5), which contains inner cell mass (ICM) and 
trophoblast. ICM cells develop toward whole body, and ESCs are established from ICM 
cells. ICM cells segregate to epiblast and primitive endoderm lineages in late blastcyst. In 
epiblast stage, Part of epiblast cells migrate to midline and form primitive streak under 
induction of Nodal secreted from node. In primitive streak, Brachyury is expressed. Wnt3a 
and Wnt5 are secreted in primitive streak and regulate expansion of primitive streak 
(Takada et al. 1994). Cells migrating through primitive streak differentiate to mesoderm and 
endoderm. The outer layer cells are called endoderm that is primordia of intestines, liver, 
pancreas and so on. The rest cells in epiblast, which do not migrate, are called ectoderm that 
is primordia of neuronal system and skin. Between the layers of endoderm and ectoderm, 
mesoderm cells differentiate from primitive streak and loose epithelial markers such as E-
cadherin. Part of mesoderm cells migrate to lateral side and are called lateral plate 
mesoderm (LPM). LPM expresses Flk1 and Pdgfrα on their surface and Mesp1 that is a 
transcriptional factor regulating cardiac mesoderm (Kataoka et al., 1997; Saga et al., 2000). 
Several secreting factors are known as regulators of LPM and cardiac mesoderm formation. 
Spatial-temporal expression of Bmp4 regulates mesoderm fate. Anterior visceral endoderm 
cells secrete Noggin, Cerberus, and Dkk1, which regulate cardiac mesoderm formation 
thorough inhibition of BMP and Wnt signaling (Foley and Mercola, 2005). Non canonical 
Wnt family, Wnt11 is also known to be involved in cardiac mesoderm to heart development 
(Pandur et al., 2002). LPM cells migrate anteriorly and forms cardiac crescent, which 
expresses Nkx2.5 and/or Islet1. Nkx2.5+ population called first heart field and Islet1+ 
population called second heart field. Cardiac crescent cells migrate and fuse in midline and 
form heart tube. Then heart tube loops rightward to form four-chambered heart. First heart 
field mainly contributes to left ventricle and second heart field contributes to atrium and 
right ventricle. 
2.2 Cardiomyocyte differentiation in vitro – Embryoid body method 
In ESC/iPSC differentiation, EB method is widely used (Figure 1). This method is rather 
easy to differentiate ESC/iPSC toward various cell types. However, it is hard to evaluate 
exact molecular mechanisms and monitor at single cell level. Using EB method in cardiac 
differentiation, beating EB in total EB rate is widely used for quantitative evaluation. During 
differentiation process, some mesoderm (Brachyury, Mesp1, Flk1, and Pdgfra) or cardiac 
markers (Nkx2.5, Islet1, actinin, αMHC and etc.) are used.  These markers were evaluated 
using RT-PCR or transgenic line in some cases. Other than transgenic line or cell surface 
antigen, it is hard to evaluate in single cellular level for differentiation step. Some growth 
factors mentioned above increase cardiac differentiation. Wnt3a have been shown to have 
stage specific and bi-phasic effect (Naito et al., 2006; Ueno et al., 2007). Wnt3a treatment 
increased cardiac differentiation in early stage of differentiation and decreased in late stage. 
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Fig. 1. Heart development in embryo and cardiac differentiation from ESCs in vitro. Cardiac 
lineage is mainly differentiate through primitive streak, lateral plate mesoderm, and cardiac 
crescent. Cardiac crescent cells migrate and fuse at midline of embryo and form heart 
primordial called heart tube. ESCs are established from inner cell mass of blastcyst. When 
ESCs are cultured in suspension, they form embryoid body, spontaneously differentiate and 
start beating when cardiomyocyte appear. Another differentiation method using 2D culture 
with sequential sorting provide us to understand stage specific prosess of differentiation. 
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Administration of Wnt11 in late stage of EB increase cardiomyocyte differentiation (Terami 
et al., 2004). Short term exposure of Noggin also directed ESCs to cardiac differentiation 
(Yuasa et al., 2005). Recently, directed differentiation methods using Activin A and BMP4 in 
EBs or high density culture of human ESCs were reported (Buehr et al., 2008; Laflamme et 
al., 2007). As shown here, some cardiogenic growth factors have been reported similar to 
embryo development. However these studies are still not clear to show the molecular 
mechanisms or target cells because of heterogeneity of cells in EBs or high density culture. 
2.3 Cardiomyocyte differentiation in vitro – Two-dimensional culture and sequential 
differentiation 
To overcome the weak points of EB method, we have developed a novel differentiation 
method using two-dimensional culture and FACS. In this method, we can systemically 
induce cardiovascular cells – cardiomyocyte, endothelial cells, pericyte, and hematopoietic 
cells from single Flk1 positive mesoderm cells (Figure 2). Withdrawal of LIF induces 
ESC/iPSC differentiation. Flk1+ mesoderm cells appear during 4-4.5 days after LIF 
withdrawal. Flk1+ cells are negative for E-cadherin, an ESC marker, and positive for Pdgfra. 
As previously reported (Kataoka et al., 1997), Flk1+/Pdgfra+ cells are observed wedge-
shaped areas on proximal lateral mesoderm of mid-late streak stage embryo (E7.0) and are 
also observed in the anterior head fold region of head fold stage embryos (E7.5-7.75), which 
might consistent with cardiac crescent. Purified Flk1+ cells give rise to cardiomyocyte after 
3-4 days coculture on OP9 feeder cells. Endothelial cells, hematopoietic cells, and pericytes 
are also observed in Flk1 culture on OP9. At Flkd2, small subset of Flk1 progeny, 
Flk1+/CXCR4+/VE-cadherin- (FCV) cells appear and almost all cardiomyocytes are from 
this FCV population (Yamashita et al., 2005). Even single Flk1+ and FCV cells can give rise to 
all these cardiovascular cells on OP9 feeder cells. Thus, it let us to know how much Flk1+ 
and FCV cells have the differentiation potentials and to observe differentiation process 
under time lapse imaging (Eilken et al., 2009). Using this system, we can determine 
differentiation stage specific event and target cells.  
In the heart, there are some subsets of cardiomyocytes, ventricular and atrial 
cardiomyocytes, conduction system cells, and pacemaker cells. Some molecular markers are 
known for these cardiomyocytes, such as myosin light chain (Mlc2v and Mlc2a), gap junction 
protein, and ion channels (Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels, 
L and T type Ca channels, Na channels and K channels). Electrophysiological study clearly 
distinguishes them in single cellular level. In early differentiation stage (such as Flkd9.5), 
ESC derived cardiomyocytes show almost homogeneous phenotype, like heart tube stage. 
Cardiomyocytes have automaticity, higher maximum diastolic potential, and slower 
maximum stroke velocity (dV/dt). On the other hand, in late differentiation stage (such as 
Flkd23.5), cardiomyocytes show diverse character – (1) automaticity+, higher maximum 
diastolic potential and slower dV/dt (2) automaticity-, deep resting membrane potential, 
and faster dV/dt (Yanagi et al., 2007).  
2.4 2D culture for EC differentiation 
Flk1 positive cells are also able to differentiate to endothelial cells and pericyte on collagen IV 
dish with VEGF or in Collagen gel as well as on OP9 cells (Yamashita et al., 2000). 
Administration of cAMP with VEGF enhanced arterial endothelial cell differentiation (Yurugi-
Kobayashi et al., 2006). Furthermore, this system clearly reconstituted downstream signals of 
cAMP. PKA enhance endothelial differentiation through enhancing VEGF signaling by 
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Fig. 2. Cardiac lineage differentiation from Flk1+ mesoderm cells. Cardiomyocytes are 
differentiated from Flk +cells on OP9 feeder cells. Self-beating cardiomyocyte appears 3-4 
days after Flk1 +cells are cultured on OP9 cells (Flkd3-4). At Flkd2, cardiogenic potential is 
restricted in Flk1 + /CxCR4 +/VE-cadherin-(FCV) population. Endothalial cells are 
differentiated from same Flk1 + cells on OP9 cells and on Collagen IV coated dish with 
VEGF. (modified from Yamashita et al., 2005) 
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 up-regulation of Flk1 and Nrp1, which forms VEGF receptor complex (Yan et al., 2009). 
Addministration of cAMP also activate Notch and β-catenin, which form transcriptional 
complex to increase arterial endothelial cell differentiation (Yamamizu et al., 2010). 
3. Chemical biology in stem cell biology 
ESC Differentiation methods have been developed based on embryology as described 
above. Recently, combined with chemical biology, it has come to next stage. In this section, 
we review chemical biology and show some examples of chemical biology combined with 
stem cell biology 
3.1 What is chemical biology? 
Chemical biology or chemical genetics is the study to elucidate biological systems with 
small molecules that bind directly to proteins to alter protein function. There are two ways 
of chemical biology: forward chemical genetics and reverse chemical genetics similar to 
conventional genetics. “Forward” means phenotype based, so random mutation is used in 
conventional genetics and screenings of small molecules, which induce phenotype of 
interest, are used in chemical genetics. “Reverse” means target based, so that gene-targeting 
and transgenic animals, and RNA interference technologies are used in conventional 
genetics, and target-specific small molecules, such as kinase inhibitors, are used in chemical 
genetics. The concept itself is not so much different; however, chemical genetics have great 
advantages and some disadvantages compared to conventional method. Small molecules 
have great advantages in temporal control, rapid inhibition or activation, and regulation of 
functionally overlapping targets, compared to conventional method. However, they also 
have some disadvantages in target specificity and off-target effect. To verify or confirm the 
targets of small molecules are more difficult.  
When chemical biology is combined with stem cell biology, some screening system is 
required to screen chemical libraries. High throughput screening (HTS) is one of 
conventional and highly efficient method to screen chemicals, in which such as plate reader 
is used to measure biological output (luciferase activity, etc.). Recent advances of imaging 
system provide a novel screening method, named high content screening (HCS), which is 
based on microscopes. In HCS, immunostained wells are photographed and scored using 
computer automatically to measure immunoreactive area or to count number of cells that 
show appropriate phenotypes.  
3.2 Chemical biology in cardiomyocyte differentiation 
In this section, we describe some example of cardiogenic small molecules. 
Ascorbic acid is a firstly identified chemical that increased cardiomyocyte differentiation 
from ESC (Takahashi et al., 2003). Ascorbic acid was identified from “The FDA2000 Drug 
Library”, which contains 880 of bioactive compounds approved for human use. In this 
screen, the authors used an ESC line carring αMHC-EGFP. The only compound found to 
reproducibly induce differentiation in monolayer culture was ascorbic acid. Interstingly, 
ascorbic acid showed no significant effect in cardiac differentiation using EB formation. 
Cardiogenol was identified from 100,000 compound library using P19, embryonic carcinoma 
cell line, stably transfected rat atrial natiuretic factor promoter-luciferace (ANF-luc) vecter 
(Wu et al., 2004). In this ANF-luc reporter assay, Approximately 80 compounds were 
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identified and 35 of 80 compounds induced MHC expression in P19CL6. 4 
diaminopyrimidines, cardiogenol A-D were the most potent in inducing MHC expression. 
Wu et al. also tested R1, a mouse ESC line, to confirm the effects of cardiogenol. R1 cells 
were cultured in extremely high density (10,000cells/well in gelatin coarted 384-well plate) 
with cardiogenol treatment in first 3 days of 7 days culture period. Although the authors did 
not mention about the molecular machineries or differentiation stage specificity, R1 cells 
were treated in early differentiation stage indicating  cardiogenol may induce cardiogenic 
mesoderm.  
Sulfonylhydrazone (Shz-1) was identified from 147,000 compund library using P19CL6, 
stably transfected bacterial artificial chromosome (BAC) of Nkx2.5 locus, which luciferase is 
knocked-in (Nkx2.5-luc) (Sadek et al., 2008). 3,000 strong positive hits from the primary 
screen were selected and 1,600 compounds were still positive for the secondary screen using 
dose response strategy. The authors clustered these hits into 10 lists of families with 
chemically distinct, synthetically tractable core structural motifs. Shz was one of the 
strongest lead chemicals. 48 hr treatment of Szh-1 at 5μM increased Nkx2.5-luc activity and 
72hr Shz1 treatment increased sarcomeric α-tropomyosin expression in P19CL6. They also 
tested SM1 ES cells. Because 48hr after treatment of Shz-1 endogenous myocardin and 
Brachyury expression level was increased, Shz-1 might also increase cardiac mesoderm 
differentiation. They tested various signal cascades to indentify Shz-1 target molecules but 
failed. They also demonstrated Shz1 increased cardiac differentiation from human M-
PBMCs in vitro. Shz1 treated M-PBMCs rescued Cryoinjured rat heart.  
 
Compound structure Assay Screened 
compound 
number 
Molecular 
mecahnisms 
Ascoribic acid 
 
αMHC-
EGFP 
ESC 
880 Unknown 
Cardiogenol C 
 
ANF-Luc 
P19 
100,000 Unknown 
Szh-1 
 
Nkx2.5-
Luc 
P19CL6 
147,000 Unknown 
Table 1. Cardiogenic chemicals 
3.3 Chemical biology in maintenace and generation of pluripotent stem cells 
Efficient maintenance and generation method of ESCs and iPSCs are also important for 
cardiac differentiation and for stem cell biology. Here we describe recent advances of 
chemical biology in maintenance and generation of ESC/iPSC.  
Mouse ESCs require LIF for their maintenance. Pluripotin was identified for the replacement 
of LIF from 50,000 compound library as activating Oct3/4-GFP transgene in ESC (Chen et 
al., 2006). Using affinity chromatography, ERK1 and RasGAP were identified as the 
molecular targets of pluripotin. Using similar Oct3/4-GFP transgenic mice, E-616452 a  
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Compound structure Primary Assay 
Screened 
compound 
number 
Molecular 
mechanisms 
Pluripotin 
 
Oct3-GFP 50,000 
ERK/Ras-GAP 
inhibition 
E-616452 
 
Oct3-GFP 800 
Tgfbr1 
inhibition 
BIX01294 
 
G9a/GLP 
inhibition 
BayK8644 
 
L type Ca 
channel agonist 
RG108 
 
ALP positive 
colony number 
2,000 
Dnmt 
inhibition 
Table 2. Small molecules identified for mainenance of ESC/iPSC and generation of iPSC 
using forward chemical genetics.  
 
Compound structure Primary Assay Molecular mechanisms 
5-azacytidine 
 
Oct3-GFP (%) 
from partially 
reprogrammed 
cells. 
DNA methylation 
inhbition 
Valproic acid 
 
Oct3-GFP 
colony number 
HDAC inhibition 
SB431542 
 
ALP positive 
colony number 
Promoting 
Mesenchymal-epithelial 
transition through TGFβ 
signal inhibition 
Table 3. Small molecules identified for maintenance of ESC/iPSC and generation of iPSC 
using reverse chemical genetics 
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Tgfbr1 inhibitor was identified as an alternative of Sox2 transgenes in generation of iPSCs 
from 800 compounds (Ichida et al., 2009). BIX01294 (G9a/GLP inhibitor), BayK8644 (L type 
Ca channel agonist) and RG108 (Dnmt inhibitor) were also identified that they could 
enhance reprogramming through screening of 2,000 bioactive molecules. These chemicals 
are identified through phenotype-based screening, so that forward chemical genetics was 
used for identification of them.  
Using reverse chemical genetics, some important findings for maintenance and generation 
of ESCs/iPSCs were reported. As FGF4/ERK signaling is a promoter signal to induce 
differentiation of mouse ESCs, inhibition of FGF4/ERK using SU5402 and PD184352 
suppressed ESC differentiation without LIF. In this condition, apoptosis was relatively high. 
To reduce apoptosis and increase ESC growth, CHIR99021 a specific GSK3 inhibitor was 
combined with SU5402 and PD184352. This three-inhibitor combination 
SU5402+PD184352+CHIR99021 (3i) support the maintenance of ESCs without Stat3 that is 
indispensable downstream target of LIF (Ying et al., 2008). Furthermore, 3i supported to 
generate rat ESCs (Buehr et al., 2008).  
Generating iPSCs is robustly studied using small molecules such as 5-azacitidine (Mikkelsen 
et al., 2008), valproic acid (Huangfu et al., 2008) and TGFβ inhibitor (Lin et al., 2009) with 
reverse genetics to elucidate the machineries of reprogramming.  
3.4 Chemical biology in other lineage differentiation 
As like cardiogenic chemicals and small molecules for maintenance and generation of 
ESC/iPSC, Douglas A. Melton and his colleagues reported some small molecules induce 
definitive endoderm and pancreatic lineage differentiation using HCS (Borowiak et al., 2009; 
Chen et al., 2009). Inducers of definitive endoderm (IDE) 1 and 2 were identified from 4,000 
 
 
Compound structure Assay 
Screened 
compound 
number 
Molecular 
targets 
IDE1 
 
IDE2 
 
Sox17-DsRed 4,000 
Trans-activate 
TGFβ/nodal 
signaling 
Indolactam V 
 
Pdx1 staining 5,000 
Activate PKC 
signaling 
 
Table 4. Small molecules using endodermal lineage induction from ESC/iPSC 
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compounds using Sox17-dTomato mESC line to replace Activin A for the initial induction of 
endoderm. IDE-1 and 2 transactivate TGFβ/Activin A/nodal signaling through unknown 
machinery. (-)-Indolactam V was identified from 5,000 compounds as inducing 
differentiation of Pdx1+ pancreatic progenitor from definitive endoderm derived from 
human ESCs using high content screening. Activation of PKC signaling is the major 
pathway of the induction of Pdx1+ pancreatic progenitor using Indolactam V. 
4. An immunosuppressant cyclosporin-A induced cardiac progenitor and 
cardiomyocyte differentaion 
We reported cyclosporin-A, an immunosuppressant specifically and efficiently induce 
cardiac progenitors and cardiomyocytes from mesoderm cells (Yan et al., 2009). In this 
section, we summarize our results (Figure 3 and 4).  
4.1 CsA induced cardiac progenitors and cardiomyocyte differentiation from 
mesoderm cells. 
Addition of CsA (1-3μg/mL) to Flk1+ cells on OP9 showed a striking effect to increase 
cardiomyocyte differentiation at Flkd6. Cardiac troponin T positive area was increased more 
than 10 times and 60% of Flk1+ cell-derived cells became αMHC-GFP+ cardiomyocytes in 
maximum. To clarify stage specificity, we added CsA during the differentiation stage of 
undifferentiated ESC–Flkd0, Flkd0-d2, and Flkd2-d6. CsA most potently showed the 
cardiogenic effect during Flkd0-2. Thus, we evaluated CsA effect on FCV cardiac progenitor 
differentiation and demonstrated that CsA treatment potently increased cardiac progenitor 
differentiation more than 20 times. Interestingly, CsA treatment strongly suppressed 
endothelial or hematopoietic differentiation suggesting that CsA may shift the cell fate from 
hemangiogenic to cardiogenic.  
4.2 Character, expanded cardiac progenitor  
Expanded FCV progenitor cells express Flk1, Cxcr4, Gata4, Nkx2.5, and Islet1 but not myosin 
chains nor ion channels. Nkx2.5 and Islet1 are the markers for the first and second heart field 
respectively, which were reported as cardiac progenitor markers in ESC differentiation 
(Moretti et al., 2006; Wu et al., 2006). In FCV cells, approximately 24% of FCV cells were 
positive for Nkx2.5, 42% were positive Islet1, and 14% were double positive for Nkx2.5 and 
Islet1. This efficient expansion of the rare FCV progenitor cells allowed us to confirm their 
cardiogenic potential in vivo. We performed transplantation of CsA-induced FCV cells to rat 
chronic myocardial infarction model. At 2 weeks after the injection, transplanted FCV cells 
were successfully differentiated into cardiomyocytes and integrated in the infarct heart. This 
result indicates that CsA-expanded FCV cells can show highly cardiogenic potentials also in 
vivo after cell transplantation. 
Cardiomyocytes induced using CsA express various cardiac markers such as Gata4, Tbx3, 
Nkx2.5, Islet1 and multiple myosin chains.  Cardiomyocytes also have apparent sarcomere 
structure, and pacemaker like potential with spontaneous beating or quiescent ventricular 
type potential.  
4.3 Molecular mechanism of cyclosporin A 
Cyclosporin A is known as inhibitor of Calcineurin-NFAT signaling. To elucidate whether 
NFAT cascade is important to inducing cardiomyocyte differentiation, we tested various 
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Fig. 3. An immunosuppressant cyclosporin A strikingly induce differentiation of FCV 
cardiac progenitor and cardiomyocytes. 
Addministration of cyclosporin A increased FCV cardiac progenitor differentiation about 20 
fold and cardiomyocyte differentiation about 10 fold with reciprocal inhibition of 
endotheleal differentiation. (modified from Yan et al., 2009) 
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Fig. 4. Characters of expanded FCV cardiac progenitor cells and cardiomyocytes. (A) mRNA 
expression in purified FCV cardiac progenitor cells and aMHC-GFP+ cardiomyocytes.  
(B) Quantitative analysis of immunostaining for Islet1 and Nkx2.5 in purified FCV cells.  
(C) Cardiogenic potential of FCV cells in vivo. Purified FCV cells were injected into rat 
chronic myocardial infarction model. Green: aMHC-EGFP+ donor derived cardiomyocytes, 
Red: cardiac troponin T+ donor and recipient cardiomyocytes, Blue:DAPI (D) Appearance of 
isolated cardiomyocyte. Apparent sarcomere structure was observed. Red: Actinin, Blue: 
DAPI. (E) Action potential of isolated cardiomyocyte. Both of pacemaker like potential with 
spontaneous beating and quiescent ventricular type potential were observed. (modified 
from Yan et al., 2009) 
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Fig. 5. Application of 2D differentiation system to HTS and HCS. Flk+1 cells are sorted 
directly on OP9-plated 96 well dish and treated with each chemical from chemical library. 
After 6 days, hight throughput screening (HTS) or high content screening (HCS) is carried 
out for measuring cardiomyocyte differentiation. HCS provide clear and efficient results 
than HTS, which show high background level. 
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NFAT signal inhibitors – FK506, VIVID (NFAT inhibitor) and cypermethrin. All of NFAT 
inhibitors failed to induce cardiomyocyte differentiation. On the other hand, NFAT 
inhibitors strongly inhibited endothelial differentiation. These results indicate that CsA 
effect on cardiomyocyte induction is through unknown pathway, and CsA effect on 
endothelial induction is through NFAT signaling. 
5. Extension to HTS and HCS 
The finding of CsA prompted us to apply our system to HTS and/or HCS (Figure 5).  We 
first developed HTS using αMHC-GFP ESCs to determine cardiac differentiation. We found 
this system could work but it showed high background signals and low signals to noise 
ratio because of lower dynamic range of GFP (Willems et al., 2009). Thus, to validate the 
result we needed to reanalyze using immunostaining or flow cytometry. We then developed 
HCS using αMHC-GFP and cTnT staining, next. HCS required us some development for 
imaging and analyzing for the assay and it took much more time for staining and imaging 
than HTS.  As expected, it showed lower background and higher signal to noise ratio than 
HTS. The balance between the data quality and cost and/or time should be considered to 
choose HTS or HCS.  
Recently we have identified novel cardiogenic effects of natural compounds that strongly 
promote cardiac differentiation from Flk1+ mesoderm cells using this HTS combined with 
HCS for validation of the results (Fukushima et al., unpublished). We also have identified 
some cardiomyocyte proliferating chemicals using HCS to directly count cardiomyocyte 
number and analyze cell cycle (Uosaki et al., unpublished).  
6. Conclusion 
Cardiac development in vivo and in vitro, chemical biology combined with stem cells, and 
comparison of HTS and HCS are described here. In chemical biology, it is of course 
important to identify and clarify how chemicals work and what molecular mechanisms are. 
Indeed it is difficult in some case, chemical biology would greatly improve and accelerate 
stem cell biology, which has been based on embryonic development.  
7. References 
Borowiak, M., Maehr, R., Chen, S., Chen, A.E., Tang, W., Fox, J.L., Schreiber, S.L., and 
Melton, D.A. (2009). Small molecules efficiently direct endodermal differentiation 
of mouse and human embryonic stem cells. Cell stem cell 4, 348-358. 
Buehr, M., Meek, S., Blair, K., Yang, J., Ure, J., Silva, J., McLay, R., Hall, J., Ying, Q.L., and 
Smith, A. (2008). Capture of authentic embryonic stem cells from rat blastocysts. 
Cell 135, 1287-1298. 
Chen, S., Borowiak, M., Fox, J.L., Maehr, R., Osafune, K., Davidow, L., Lam, K., Peng, L.F., 
Schreiber, S.L., Rubin, L.L., et al. (2009). A small molecule that directs 
differentiation of human ESCs into the pancreatic lineage. Nat Chem Biol 5, 258-
265. 
Chen, S., Do, J.T., Zhang, Q., Yao, S., Yan, F., Peters, E.C., Schöler, H.R., Schultz, P.G., and 
Ding, S. (2006). Self-renewal of embryonic stem cells by a small molecule. Proc Natl 
Acad Sci U S A 103, 17266-17271. 
www.intechopen.com
Chemicals Regulating Cardiomyocyte Differentiation   
 
485 
Eilken, H.M., Nishikawa, S., and Schroeder, T. (2009). Continuous single-cell imaging of 
blood generation from haemogenic endothelium. Nature 457, 896-900. 
Foley, A.C., and Mercola, M. (2005). Heart induction by Wnt antagonists depends on the 
homeodomain transcription factor Hex. Genes Dev 19, 387-396. 
Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A.E., and Melton, 
D.A. (2008). Induction of pluripotent stem cells by defined factors is greatly 
improved by small-molecule compounds. Nat Biotechnol 26, 795-797. 
Ichida, J.K., Blanchard, J., Lam, K., Son, E.Y., Chung, J.E., Egli, D., Loh, K.M., Carter, A.C., Di 
Giorgio, F.P., Koszka, K., et al. (2009). A small-molecule inhibitor of tgf-Beta 
signaling replaces sox2 in reprogramming by inducing nanog. Cell stem cell 5, 491-
503. 
Kataoka, H., Takakura, N., Nishikawa, S., Tsuchida, K., Kodama, H., Kunisada, T., Risau, 
W., Kita, T., and Nishikawa, S.I. (1997). Expressions of PDGF receptor alpha, c-Kit 
and Flk1 genes clustering in mouse chromosome 5 define distinct subsets of 
nascent mesodermal cells. Dev Growth Differ 39, 729-740. 
Laflamme, M.A., Chen, K.Y., Naumova, A.V., Muskheli, V., Fugate, J.A., Dupras, S.K., 
Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007). Cardiomyocytes 
derived from human embryonic stem cells in pro-survival factors enhance function 
of infarcted rat hearts. Nat Biotechnol 25, 1015-1024. 
Lin, T., Ambasudhan, R., Yuan, X., Li, W., Hilcove, S., Abujarour, R., Lin, X., Hahm, H.S., 
Hao, E., Hayek, A., et al. (2009). A chemical platform for improved induction of 
human iPSCs. Nat Methods 6, 805-808. 
Mikkelsen, T.S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B.E., 
Jaenisch, R., Lander, E.S., and Meissner, A. (2008). Dissecting direct reprogramming 
through integrative genomic analysis. Nature 454, 49-55. 
Moretti, A., Caron, L., Nakano, A., Lam, J.T., Bernshausen, A., Chen, Y., Qyang, Y., Bu, L., 
Sasaki, M., Martin-Puig, S., et al. (2006). Multipotent embryonic isl1+ progenitor 
cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127, 
1151-1165. 
Naito, A., Shiojima, I., Akazawa, H., Hidaka, K., Morisaki, T., Kikuchi, A., and Komuro, I. 
(2006). Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling 
in cardiomyogenesis and hematopoiesis. Proc Natl Acad Sci U S A 103, 19812-
19817. 
Pandur, P., Läsche, M., Eisenberg, L.M., and Kühl, M. (2002). Wnt-11 activation of a non-
canonical Wnt signalling pathway is required for cardiogenesis. Nature 418, 636-
641. 
Sadek, H., Hannack, B., Choe, E., Wang, J., Latif, S., Garry, M.G., Garry, D.J., Longgood, J., 
Frantz, D.E., Olson, E.N., et al. (2008). Cardiogenic small molecules that enhance 
myocardial repair by stem cells. Proc Natl Acad Sci U S A 105, 6063-6068. 
Saga, Y., Kitajima. S,, Miyagawa-Tomita. S. (2000). Mesp1 expression is the earliest sign of 
cardiovascular development. Trends Cardiovasc Med. 10, 345-52. 
Takahashi, T., Lord, B., Schulze, P.C., Fryer, R.M., Sarang, S.S., Gullans, S.R., and Lee, R.T. 
(2003). Ascorbic acid enhances differentiation of embryonic stem cells into cardiac 
myocytes. Circulation 107, 1912-1916. 
www.intechopen.com
 Embryonic Stem Cells: The Hormonal Regulation of Pluripotency and Embryogenesis 
 
486 
Terami, H., Hidaka, K., Katsumata, T., Iio, A., and Morisaki, T. (2004). Wnt11 facilitates 
embryonic stem cell differentiation to Nkx2.5-positive cardiomyocytes. Biochem 
Biophys Res Commun 325, 968-975. 
Ueno, S., Weidinger, G., Osugi, T., Kohn, A.D., Golob, J.L., Pabon, L., Reinecke, H., Moon, 
R.T., and Murry, C.E. (2007). Biphasic role for Wnt/beta-catenin signaling in 
cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci U S 
A 104, 9685-9690. 
Willems, E., Bushway, P.J., and Mercola, M. (2009). Natural and Synthetic Regulators of 
Embryonic Stem Cell Cardiogenesis. Pediatric Cardiology. 
Wu, S.M., Fujiwara, Y., Cibulsky, S.M., Clapham, D.E., Lien, C.L., Schultheiss, T.M., and 
Orkin, S.H. (2006). Developmental origin of a bipotential myocardial and smooth 
muscle cell precursor in the mammalian heart. Cell 127, 1137-1150. 
Wu, X., Ding, S., Ding, Q., Gray, N.S., and Schultz, P.G. (2004). Small molecules that induce 
cardiomyogenesis in embryonic stem cells. J Am Chem Soc 126, 1590-1591. 
Yamamizu, K., Matsunaga, T., Uosaki, H., Fukushima, H., Katayama, S., Hiraoka-Kanie, M., 
Mitani, K., and Yamashita, J.K. (2010). Convergence of Notch and beta-catenin 
signaling induces arterial fate in vascular progenitors. J Cell Biol 189, 325-338. 
Yamashita, J., Itoh, H., Hirashima, M., Ogawa, M., Nishikawa, S., Yurugi, T., Naito, M., and 
Nakao, K. (2000). Flk1-positive cells derived from embryonic stem cells serve as 
vascular progenitors. Nature 408, 92-96. 
Yamashita, J.K., Takano, M., Hiraoka-Kanie, M., Shimazu, C., Peishi, Y., Yanagi, K., Nakano, 
A., Inoue, E., Kita, F., and Nishikawa, S. (2005). Prospective identification of cardiac 
progenitors by a novel single cell-based cardiomyocyte induction. FASEB J 19, 
1534-1536. 
Yan, P., Nagasawa, A., Uosaki, H., Sugimoto, A., Yamamizu, K., Teranishi, M., Matsuda, H., 
Matsuoka, S., Ikeda, T., Komeda, M., et al. (2009). Cyclosporin-A potently induces 
highly cardiogenic progenitors from embryonic stem cells. Biochem Biophys Res 
Commun 379, 115-120. 
Yanagi, K., Takano, M., Narazaki, G., Uosaki, H., Hoshino, T., Ishii, T., Misaki, T., and 
Yamashita, J.K. (2007). Hyperpolarization-activated cyclic nucleotide-gated 
channels and T-type calcium channels confer automaticity of embryonic stem cell-
derived cardiomyocytes. Stem cells 25, 2712-2719. 
Ying, Q.L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., and 
Smith, A. (2008). The ground state of embryonic stem cell self-renewal. Nature 453, 
519-523. 
Yuasa, S., Itabashi, Y., Koshimizu, U., Tanaka, T., Sugimura, K., Kinoshita, M., Hattori, F., 
Fukami, S., Shimazaki, T., Ogawa, S., et al. (2005). Transient inhibition of BMP 
signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic 
stem cells. Nat Biotechnol 23, 607-611. 
Yurugi-Kobayashi, T., Itoh, H., Schroeder, T., Nakano, A., Narazaki, G., Kita, F., Yanagi, K., 
Hiraoka-Kanie, M., Inoue, E., Ara, T., et al. (2006). Adrenomedullin/cyclic AMP 
pathway induces Notch activation and differentiation of arterial endothelial cells 
from vascular progenitors. Arterioscler Thromb Vasc Biol 26, 1977-1984. 
 
 
www.intechopen.com
Embryonic Stem Cells: The Hormonal Regulation of Pluripotency
and Embryogenesis
Edited by Prof. Craig Atwood
ISBN 978-953-307-196-1
Hard cover, 672 pages
Publisher InTech
Published online 26, April, 2011
Published in print edition April, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Pluripotency is a prerequisite for the subsequent coordinated differentiation of embryonic stem cells into all
tissues of the body. This book describes recent advances in our understanding of pluripotency and the
hormonal regulation of embryonic stem cell differentiation into tissue types derived from the ectoderm,
mesoderm and endoderm.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Hideki Uosaki and Jun K Yamashita (2011). Chemicals Regulating Cardiomyocyte Differentiation, Embryonic
Stem Cells: The Hormonal Regulation of Pluripotency and Embryogenesis, Prof. Craig Atwood (Ed.), ISBN:
978-953-307-196-1, InTech, Available from: http://www.intechopen.com/books/embryonic-stem-cells-the-
hormonal-regulation-of-pluripotency-and-embryogenesis/chemicals-regulating-cardiomyocyte-differentiation
© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
